Jazz Pharmaceuticals plc Tangible Net Worth Ratio
Jazz Pharmaceuticals plc tangible net worth ratio. Jazz Pharmaceuticals plc (J7Z) has a Tangible Net Worth Ratio of 7.2% as of March 2026. This metric is calculated by deducting intangible assets (€4.20 Billion) from net assets (€4.53 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Jazz Pharmaceuticals plc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Jazz Pharmaceuticals plc (2013–2025)
Tangible net worth ratio of Jazz Pharmaceuticals plc from 2013 to 2025. This chart shows how Jazz Pharmaceuticals plc's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 7.2%, reflecting net assets of €4.53 Billion with intangible assets of €4.20 Billion EUR. Check Jazz Pharmaceuticals plc (J7Z) strategic investment index to assess the company's strategic physical and investment asset allocation.
Jazz Pharmaceuticals plc Tangible Net Worth Ratio by Year (2013–2025)
Jazz Pharmaceuticals plc tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Jazz Pharmaceuticals plc from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see J7Z market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -2.6% | €4.32 Billion | €4.43 Billion | €11.66 Billion | ▲ +13.6 pp |
| 2024 | -16.2% | €4.09 Billion | €4.76 Billion | €12.01 Billion | ▲ +28.8 pp |
| 2023 | -45.0% | €3.74 Billion | €5.42 Billion | €11.39 Billion | ▲ +42.8 pp |
| 2022 | -87.8% | €3.09 Billion | €5.79 Billion | €10.84 Billion | ▼ -7.4 pp |
| 2021 | -80.4% | €3.97 Billion | €7.15 Billion | €12.30 Billion | ▼ -120.4 pp |
| 2020 | 40.0% | €3.66 Billion | €2.20 Billion | €6.54 Billion | ▲ +18.5 pp |
| 2019 | 21.5% | €3.11 Billion | €2.44 Billion | €5.54 Billion | ▲ +20.6 pp |
| 2018 | 0.9% | €2.76 Billion | €2.73 Billion | €5.20 Billion | ▲ +10.8 pp |
| 2017 | -9.8% | €2.71 Billion | €2.98 Billion | €5.12 Billion | ▲ +50.6 pp |
| 2016 | -60.4% | €1.88 Billion | €3.01 Billion | €4.80 Billion | ▼ -86.3 pp |
| 2015 | 25.8% | €1.60 Billion | €1.19 Billion | €3.33 Billion | ▲ +30.7 pp |
| 2014 | -4.8% | €1.37 Billion | €1.44 Billion | €3.34 Billion | ▼ -42.1 pp |
| 2013 | 37.3% | €1.30 Billion | €812.40 Million | €2.24 Billion | — |